How many patents does
Agensys have?
patents
800
families
79
granted
238
applications
562
US
246
EP
85
JP
40
WO
21
CN
16
KR
10
RoW
382
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Agensys
Top ten assignees appearing on patents
2009 - 2018
| agensys | 709 |
| seattle genetics | 80 |
| urogenesys | 4 |
| ehdzhensis | 2 |
| genentech | 2 |
| agansys | 1 |
| synthetic genetics | 1 |
2018
| agensys | 43 |
| seattle genetics | 21 |
Agensys
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| antibody drug conjugates (adc) that bind to 191p4d12 proteins | 51 | 2010 |
| nucleic acid and corresponding protein entitled 282p1g3 useful in treatment and detectio… 🛈 | 40 | 2002 |
| serpentine transmembrane antigens expressed in human cancers and uses thereof | 34 | 1998 |
| prostate stem cell antigen (psca) variants and subsequences thereof | 33 | 2003 |
| antibody drug conjugates (adc) that bind to 158p1d7 proteins | 31 | 2012 |
| antibody drug conjugates (adc) that bind to 161p2f10b proteins | 30 | 2010 |
| nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detectio… 🛈 | 28 | 2001 |
| c-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof | 28 | 1999 |
| nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detect… 🛈 | 26 | 2001 |
| methods of inducing an immune response | 25 | 2001 |